Work

Endometrial cancer risk in estrogen users after switching to estrogen–progestin therapy

Year: 2007

Type: article

Study design: Observational Study

Source: Cancer Causes & Control

DOI: 10.1007/s10552-007-9040-6

Authors: Jessica Chubak, Jennifer A. Doherty, Kara L. Cushing-Haugen, Lynda F. Voigt, Babette S. Saltzman, Deirdre A. Hill, Shirley A. A. Beresford, Noel S. Weiss

Institutions: University of Washington, Fred Hutch Cancer Center, University of New Mexico

Language: English

Topic: Menopause: Health Impacts and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: ENDOMETRIAL CANCER RISK AND POSTMENOPAUSAL HORMONE USE, Mentoring and Research in Cancer Epidemiology , G248442007, G251835456, G3161144320, BREAST CANCER AND THE BIRTH CONTROL PILL, G3310623003, G5650272604, G671768105, Molecular Epidemiology of Endometrial Cancer, ENDOMETRIAL CANCER AND POSTMENOPAUSAL HORMONE THERAPY, RESEARCH IN CANCER EPIDEMIOLOGY, Developing Data-Driven Cancer Researchers, G988737349

OpenAlex ID: W1999898430

FWCI: 0.245

Cites: 26

Cited by: 9

Related to: 10